Tonix Pharmaceuticals, Inc. 10-K
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Tonix Pharmaceuticals Holding Corp. on Form S-1 (Nos. 333-234263, 333-235976) Form S-3 (Nos. 333-224586, 333-251500, 333-237610) and Form S-8 (Nos. 333-202006, 333-212300, 333-219928, 333-226776, 333-232137, and 333-239152) of our report dated March 15, 2021, on our audit of the consolidated financial statements as of December 31, 2020 and 2019 and for each of the years then ended, which report is included in this Annual Report on Form 10-K. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern.
/s/ EisnerAmper LLP
Iselin, New Jersey
March 15, 2021